What is ADUS stock price today?

Visit our real-time dashboard for the current ADUS stock price and live market data.

Is ADUS stock going up or down today?

ADUS stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy ADUS stock now?

The decision to buy ADUS depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is ADUS a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for ADUS based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is ADUS stock overvalued or undervalued?

ADUS currently trades at a P/E ratio of 17.32 relative to earnings. Our DCF calculator provides intrinsic value estimates to help determine if ADUS is fairly priced.

What is ADUS's P/E ratio?

ADUS has a price-to-earnings (P/E) ratio of 17.32, which measures how much investors are willing to pay per dollar of earnings. Compare this to industry peers and historical averages for context.

What is ADUS's market cap?

ADUS (Addus HomeCare Corporation) has a market capitalization of $1.75 billion, making it a small-cap stock.

What is ADUS's price to book ratio?

ADUS trades at a price-to-book (P/B) ratio of 1.58, which compares the stock price to the company's book value per share. A P/B below 1.0 may indicate undervaluation, while above 3.0 may suggest premium pricing.

Does ADUS pay dividends?

ADUS does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is ADUS's dividend yield?

ADUS does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is ADUS stock a good long-term investment?

ADUS's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is ADUS's revenue growth rate?

Revenue growth data for ADUS is available on our dashboard with detailed financial statement analysis.

Profitability metrics for ADUS are available on our dashboard with complete income statement analysis.

What are the risks of investing in ADUS?

Key risks for ADUS include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does ADUS compare to its competitors?

Compare ADUS to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize ADUS's performance and positioning.

What is ADUS's stock price target for 2026?

Visit our prediction page for AI-powered price targets for ADUS with bull, base, and bear case scenarios.

What do analysts say about ADUS?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for ADUS. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is ADUS's next earnings report?

ADUS reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

ADUS - Addus HomeCare Corporation

NYSE * Healthcare * Medical Care Facilities

$0.00

+$0.00 (+0.00%)

About Addus HomeCare Corporation

Addus HomeCare Corporation (ADUS) common stock

Price Chart

Loading chart...

ADUS Key Statistics

Market Cap

$1.75B

P/E Ratio

17.32

P/B Ratio

1.58

How ADUS Compares to Peers

ADUS has the lowest P/E ratio in Medical Care Facilities, suggesting it may be the most undervalued

ADUS is the smallest among peers, which may offer higher growth potential

P/E Rank

of 6

Margin Rank

N/A

of 0

Growth Rank

N/A

of 0

Size Rank

of 6

Company	Market Cap	P/E	Growth	Margin	Compare
ADUS(This stock)	$1.75B	17.3	0%	0.0%	-
UNHUnitedHealth Group	$362.83B	30.1	0%	0.0%	vs UNH
JNJJohnson &	$375.37B	17.4	0%	0.0%	vs JNJ
LLYEli Lilly	$991.62B	39.5	0%	0.0%	vs LLY
PFEPfizer Inc	$147.73B	19.8	0%	0.0%	vs PFE
ABBVAbbVie Inc	$334.34B	80.5	0%	0.0%	vs ABBV

Data Updated: July 20, 2026 at 4:18 PM EDT

Ready to invest in ADUS?

Commission-free trading available. Affiliate links.

ADUS Lician Score

10% confidence

6.0/10

Good

ADUS has a Lician Score of 6/10 (Good). Strengths: Growth.

value

5.0

growth

9.0

quality

5.0

momentum

5.0

safety

5.0

The Lician Score is a comprehensive 1-10 rating that evaluates ADUSacross five key dimensions: Value (valuation relative to sector),Growth (revenue and earnings trajectory),Quality (profitability and balance sheet strength),Momentum (price trends and analyst sentiment), andSafety (volatility and risk metrics).

ADUS Financial Snowflake

5-axis analysis across key investment dimensions

5.8/10

Neutral

5.0

Value

Valuation vs. sector peers

9.0

Growth

Revenue & earnings trajectory

5.0

Quality

Profitability & moat strength

5.0

Momentum

Price trends & analyst sentiment

5.0

Safety

Financial stability & risk

Upcoming Events for ADUS

Dashboard

Enter a ticker to analyze